Pharma & Healthcare
Global Drug Delivery System in Vivo Market Research Report 2025
- Sep 24, 25
- ID: 521785
- Pages: 117
- Figures: 114
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Delivery System in Vivo, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery System in Vivo.
The Drug Delivery System in Vivo market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Delivery System in Vivo market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery System in Vivo manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
Covis Pharma
AbbVie
Dr Reddy
AstraZeneca
Aspen Pharmacare
Acrotech Biopharma
TWi Pharmaceuticals(Bora Pharma)
Segment by Type
Carrier Formulation Delivery
Targeted Delivery
Segment by Application
Small Molecule Drug
Proteins and Peptides
Antibody
Nucleic Acids
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Delivery System in Vivo manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Delivery System in Vivo in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery System in Vivo, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery System in Vivo.
The Drug Delivery System in Vivo market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Delivery System in Vivo market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery System in Vivo manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Amgen
Teva
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer
Takeda
Bausch&Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
TOLMAR
Astellas
Covis Pharma
AbbVie
Dr Reddy
AstraZeneca
Aspen Pharmacare
Acrotech Biopharma
TWi Pharmaceuticals(Bora Pharma)
Segment by Type
Carrier Formulation Delivery
Targeted Delivery
Segment by Application
Small Molecule Drug
Proteins and Peptides
Antibody
Nucleic Acids
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Delivery System in Vivo manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Delivery System in Vivo in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Drug Delivery System in Vivo Market Overview
1.1 Product Definition
1.2 Drug Delivery System in Vivo by Type
1.2.1 Global Drug Delivery System in Vivo Market Value Comparison by Type (2024 VS 2031)
1.2.2 Carrier Formulation Delivery
1.2.3 Targeted Delivery
1.3 Drug Delivery System in Vivo by Application
1.3.1 Global Drug Delivery System in Vivo Market Value by Application (2024 VS 2031)
1.3.2 Small Molecule Drug
1.3.3 Proteins and Peptides
1.3.4 Antibody
1.3.5 Nucleic Acids
1.3.6 Others
1.4 Global Drug Delivery System in Vivo Market Size Estimates and Forecasts
1.4.1 Global Drug Delivery System in Vivo Revenue 2020-2031
1.4.2 Global Drug Delivery System in Vivo Sales 2020-2031
1.4.3 Global Drug Delivery System in Vivo Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Delivery System in Vivo Market Competition by Manufacturers
2.1 Global Drug Delivery System in Vivo Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Delivery System in Vivo Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Delivery System in Vivo Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Delivery System in Vivo, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
2.7 Global Key Manufacturers of Drug Delivery System in Vivo, Date of Enter into This Industry
2.8 Global Drug Delivery System in Vivo Market Competitive Situation and Trends
2.8.1 Global Drug Delivery System in Vivo Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Delivery System in Vivo Players Market Share by Revenue
2.8.3 Global Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Delivery System in Vivo Market Scenario by Region
3.1 Global Drug Delivery System in Vivo Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Delivery System in Vivo Sales by Region: 2020-2031
3.2.1 Global Drug Delivery System in Vivo Sales by Region: 2020-2025
3.2.2 Global Drug Delivery System in Vivo Sales by Region: 2026-2031
3.3 Global Drug Delivery System in Vivo Revenue by Region: 2020-2031
3.3.1 Global Drug Delivery System in Vivo Revenue by Region: 2020-2025
3.3.2 Global Drug Delivery System in Vivo Revenue by Region: 2026-2031
3.4 North America Drug Delivery System in Vivo Market Facts & Figures by Country
3.4.1 North America Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Delivery System in Vivo Sales by Country (2020-2031)
3.4.3 North America Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Delivery System in Vivo Market Facts & Figures by Country
3.5.1 Europe Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Delivery System in Vivo Sales by Country (2020-2031)
3.5.3 Europe Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Delivery System in Vivo Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Delivery System in Vivo Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Delivery System in Vivo Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Delivery System in Vivo Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Delivery System in Vivo Market Facts & Figures by Country
3.7.1 Latin America Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Delivery System in Vivo Sales by Country (2020-2031)
3.7.3 Latin America Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Delivery System in Vivo Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Delivery System in Vivo Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Delivery System in Vivo Sales by Type (2020-2031)
4.1.1 Global Drug Delivery System in Vivo Sales by Type (2020-2025)
4.1.2 Global Drug Delivery System in Vivo Sales by Type (2026-2031)
4.1.3 Global Drug Delivery System in Vivo Sales Market Share by Type (2020-2031)
4.2 Global Drug Delivery System in Vivo Revenue by Type (2020-2031)
4.2.1 Global Drug Delivery System in Vivo Revenue by Type (2020-2025)
4.2.2 Global Drug Delivery System in Vivo Revenue by Type (2026-2031)
4.2.3 Global Drug Delivery System in Vivo Revenue Market Share by Type (2020-2031)
4.3 Global Drug Delivery System in Vivo Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Delivery System in Vivo Sales by Application (2020-2031)
5.1.1 Global Drug Delivery System in Vivo Sales by Application (2020-2025)
5.1.2 Global Drug Delivery System in Vivo Sales by Application (2026-2031)
5.1.3 Global Drug Delivery System in Vivo Sales Market Share by Application (2020-2031)
5.2 Global Drug Delivery System in Vivo Revenue by Application (2020-2031)
5.2.1 Global Drug Delivery System in Vivo Revenue by Application (2020-2025)
5.2.2 Global Drug Delivery System in Vivo Revenue by Application (2026-2031)
5.2.3 Global Drug Delivery System in Vivo Revenue Market Share by Application (2020-2031)
5.3 Global Drug Delivery System in Vivo Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Drug Delivery System in Vivo Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Drug Delivery System in Vivo Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Drug Delivery System in Vivo Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 UCB (Union Chimique Belge)
6.4.1 UCB (Union Chimique Belge) Company Information
6.4.2 UCB (Union Chimique Belge) Description and Business Overview
6.4.3 UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB (Union Chimique Belge) Drug Delivery System in Vivo Product Portfolio
6.4.5 UCB (Union Chimique Belge) Recent Developments/Updates
6.5 Celgene
6.5.1 Celgene Company Information
6.5.2 Celgene Description and Business Overview
6.5.3 Celgene Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Celgene Drug Delivery System in Vivo Product Portfolio
6.5.5 Celgene Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Drug Delivery System in Vivo Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Gilead Sciences
6.7.1 Gilead Sciences Company Information
6.7.2 Gilead Sciences Description and Business Overview
6.7.3 Gilead Sciences Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gilead Sciences Drug Delivery System in Vivo Product Portfolio
6.7.5 Gilead Sciences Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Drug Delivery System in Vivo Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Drug Delivery System in Vivo Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Company Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takeda Drug Delivery System in Vivo Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Bausch&Lomb
6.11.1 Bausch&Lomb Company Information
6.11.2 Bausch&Lomb Description and Business Overview
6.11.3 Bausch&Lomb Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bausch&Lomb Drug Delivery System in Vivo Product Portfolio
6.11.5 Bausch&Lomb Recent Developments/Updates
6.12 Samyang Biopharmaceuticals
6.12.1 Samyang Biopharmaceuticals Company Information
6.12.2 Samyang Biopharmaceuticals Description and Business Overview
6.12.3 Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Samyang Biopharmaceuticals Drug Delivery System in Vivo Product Portfolio
6.12.5 Samyang Biopharmaceuticals Recent Developments/Updates
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Company Information
6.13.2 Johnson & Johnson Description and Business Overview
6.13.3 Johnson & Johnson Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Johnson & Johnson Drug Delivery System in Vivo Product Portfolio
6.13.5 Johnson & Johnson Recent Developments/Updates
6.14 TOLMAR
6.14.1 TOLMAR Company Information
6.14.2 TOLMAR Description and Business Overview
6.14.3 TOLMAR Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.14.4 TOLMAR Drug Delivery System in Vivo Product Portfolio
6.14.5 TOLMAR Recent Developments/Updates
6.15 Astellas
6.15.1 Astellas Company Information
6.15.2 Astellas Description and Business Overview
6.15.3 Astellas Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Astellas Drug Delivery System in Vivo Product Portfolio
6.15.5 Astellas Recent Developments/Updates
6.16 Covis Pharma
6.16.1 Covis Pharma Company Information
6.16.2 Covis Pharma Description and Business Overview
6.16.3 Covis Pharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Covis Pharma Drug Delivery System in Vivo Product Portfolio
6.16.5 Covis Pharma Recent Developments/Updates
6.17 AbbVie
6.17.1 AbbVie Company Information
6.17.2 AbbVie Description and Business Overview
6.17.3 AbbVie Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AbbVie Drug Delivery System in Vivo Product Portfolio
6.17.5 AbbVie Recent Developments/Updates
6.18 Dr Reddy
6.18.1 Dr Reddy Company Information
6.18.2 Dr Reddy Description and Business Overview
6.18.3 Dr Reddy Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Dr Reddy Drug Delivery System in Vivo Product Portfolio
6.18.5 Dr Reddy Recent Developments/Updates
6.19 AstraZeneca
6.19.1 AstraZeneca Company Information
6.19.2 AstraZeneca Description and Business Overview
6.19.3 AstraZeneca Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AstraZeneca Drug Delivery System in Vivo Product Portfolio
6.19.5 AstraZeneca Recent Developments/Updates
6.20 Aspen Pharmacare
6.20.1 Aspen Pharmacare Company Information
6.20.2 Aspen Pharmacare Description and Business Overview
6.20.3 Aspen Pharmacare Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Aspen Pharmacare Drug Delivery System in Vivo Product Portfolio
6.20.5 Aspen Pharmacare Recent Developments/Updates
6.21 Acrotech Biopharma
6.21.1 Acrotech Biopharma Company Information
6.21.2 Acrotech Biopharma Description and Business Overview
6.21.3 Acrotech Biopharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Acrotech Biopharma Drug Delivery System in Vivo Product Portfolio
6.21.5 Acrotech Biopharma Recent Developments/Updates
6.22 TWi Pharmaceuticals(Bora Pharma)
6.22.1 TWi Pharmaceuticals(Bora Pharma) Company Information
6.22.2 TWi Pharmaceuticals(Bora Pharma) Description and Business Overview
6.22.3 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.22.4 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product Portfolio
6.22.5 TWi Pharmaceuticals(Bora Pharma) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Delivery System in Vivo Industry Chain Analysis
7.2 Drug Delivery System in Vivo Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Delivery System in Vivo Production Mode & Process Analysis
7.4 Drug Delivery System in Vivo Sales and Marketing
7.4.1 Drug Delivery System in Vivo Sales Channels
7.4.2 Drug Delivery System in Vivo Distributors
7.5 Drug Delivery System in Vivo Customer Analysis
8 Drug Delivery System in Vivo Market Dynamics
8.1 Drug Delivery System in Vivo Industry Trends
8.2 Drug Delivery System in Vivo Market Drivers
8.3 Drug Delivery System in Vivo Market Challenges
8.4 Drug Delivery System in Vivo Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Drug Delivery System in Vivo by Type
1.2.1 Global Drug Delivery System in Vivo Market Value Comparison by Type (2024 VS 2031)
1.2.2 Carrier Formulation Delivery
1.2.3 Targeted Delivery
1.3 Drug Delivery System in Vivo by Application
1.3.1 Global Drug Delivery System in Vivo Market Value by Application (2024 VS 2031)
1.3.2 Small Molecule Drug
1.3.3 Proteins and Peptides
1.3.4 Antibody
1.3.5 Nucleic Acids
1.3.6 Others
1.4 Global Drug Delivery System in Vivo Market Size Estimates and Forecasts
1.4.1 Global Drug Delivery System in Vivo Revenue 2020-2031
1.4.2 Global Drug Delivery System in Vivo Sales 2020-2031
1.4.3 Global Drug Delivery System in Vivo Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Delivery System in Vivo Market Competition by Manufacturers
2.1 Global Drug Delivery System in Vivo Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Delivery System in Vivo Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Delivery System in Vivo Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Delivery System in Vivo, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
2.7 Global Key Manufacturers of Drug Delivery System in Vivo, Date of Enter into This Industry
2.8 Global Drug Delivery System in Vivo Market Competitive Situation and Trends
2.8.1 Global Drug Delivery System in Vivo Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Delivery System in Vivo Players Market Share by Revenue
2.8.3 Global Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Delivery System in Vivo Market Scenario by Region
3.1 Global Drug Delivery System in Vivo Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Delivery System in Vivo Sales by Region: 2020-2031
3.2.1 Global Drug Delivery System in Vivo Sales by Region: 2020-2025
3.2.2 Global Drug Delivery System in Vivo Sales by Region: 2026-2031
3.3 Global Drug Delivery System in Vivo Revenue by Region: 2020-2031
3.3.1 Global Drug Delivery System in Vivo Revenue by Region: 2020-2025
3.3.2 Global Drug Delivery System in Vivo Revenue by Region: 2026-2031
3.4 North America Drug Delivery System in Vivo Market Facts & Figures by Country
3.4.1 North America Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Delivery System in Vivo Sales by Country (2020-2031)
3.4.3 North America Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Delivery System in Vivo Market Facts & Figures by Country
3.5.1 Europe Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Delivery System in Vivo Sales by Country (2020-2031)
3.5.3 Europe Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Delivery System in Vivo Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Delivery System in Vivo Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Delivery System in Vivo Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Delivery System in Vivo Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Delivery System in Vivo Market Facts & Figures by Country
3.7.1 Latin America Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Delivery System in Vivo Sales by Country (2020-2031)
3.7.3 Latin America Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Delivery System in Vivo Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Delivery System in Vivo Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Delivery System in Vivo Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Delivery System in Vivo Sales by Type (2020-2031)
4.1.1 Global Drug Delivery System in Vivo Sales by Type (2020-2025)
4.1.2 Global Drug Delivery System in Vivo Sales by Type (2026-2031)
4.1.3 Global Drug Delivery System in Vivo Sales Market Share by Type (2020-2031)
4.2 Global Drug Delivery System in Vivo Revenue by Type (2020-2031)
4.2.1 Global Drug Delivery System in Vivo Revenue by Type (2020-2025)
4.2.2 Global Drug Delivery System in Vivo Revenue by Type (2026-2031)
4.2.3 Global Drug Delivery System in Vivo Revenue Market Share by Type (2020-2031)
4.3 Global Drug Delivery System in Vivo Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Delivery System in Vivo Sales by Application (2020-2031)
5.1.1 Global Drug Delivery System in Vivo Sales by Application (2020-2025)
5.1.2 Global Drug Delivery System in Vivo Sales by Application (2026-2031)
5.1.3 Global Drug Delivery System in Vivo Sales Market Share by Application (2020-2031)
5.2 Global Drug Delivery System in Vivo Revenue by Application (2020-2031)
5.2.1 Global Drug Delivery System in Vivo Revenue by Application (2020-2025)
5.2.2 Global Drug Delivery System in Vivo Revenue by Application (2026-2031)
5.2.3 Global Drug Delivery System in Vivo Revenue Market Share by Application (2020-2031)
5.3 Global Drug Delivery System in Vivo Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Drug Delivery System in Vivo Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Drug Delivery System in Vivo Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Drug Delivery System in Vivo Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 UCB (Union Chimique Belge)
6.4.1 UCB (Union Chimique Belge) Company Information
6.4.2 UCB (Union Chimique Belge) Description and Business Overview
6.4.3 UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.4.4 UCB (Union Chimique Belge) Drug Delivery System in Vivo Product Portfolio
6.4.5 UCB (Union Chimique Belge) Recent Developments/Updates
6.5 Celgene
6.5.1 Celgene Company Information
6.5.2 Celgene Description and Business Overview
6.5.3 Celgene Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Celgene Drug Delivery System in Vivo Product Portfolio
6.5.5 Celgene Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Drug Delivery System in Vivo Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Gilead Sciences
6.7.1 Gilead Sciences Company Information
6.7.2 Gilead Sciences Description and Business Overview
6.7.3 Gilead Sciences Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gilead Sciences Drug Delivery System in Vivo Product Portfolio
6.7.5 Gilead Sciences Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Drug Delivery System in Vivo Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Drug Delivery System in Vivo Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Company Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takeda Drug Delivery System in Vivo Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Bausch&Lomb
6.11.1 Bausch&Lomb Company Information
6.11.2 Bausch&Lomb Description and Business Overview
6.11.3 Bausch&Lomb Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bausch&Lomb Drug Delivery System in Vivo Product Portfolio
6.11.5 Bausch&Lomb Recent Developments/Updates
6.12 Samyang Biopharmaceuticals
6.12.1 Samyang Biopharmaceuticals Company Information
6.12.2 Samyang Biopharmaceuticals Description and Business Overview
6.12.3 Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Samyang Biopharmaceuticals Drug Delivery System in Vivo Product Portfolio
6.12.5 Samyang Biopharmaceuticals Recent Developments/Updates
6.13 Johnson & Johnson
6.13.1 Johnson & Johnson Company Information
6.13.2 Johnson & Johnson Description and Business Overview
6.13.3 Johnson & Johnson Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Johnson & Johnson Drug Delivery System in Vivo Product Portfolio
6.13.5 Johnson & Johnson Recent Developments/Updates
6.14 TOLMAR
6.14.1 TOLMAR Company Information
6.14.2 TOLMAR Description and Business Overview
6.14.3 TOLMAR Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.14.4 TOLMAR Drug Delivery System in Vivo Product Portfolio
6.14.5 TOLMAR Recent Developments/Updates
6.15 Astellas
6.15.1 Astellas Company Information
6.15.2 Astellas Description and Business Overview
6.15.3 Astellas Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Astellas Drug Delivery System in Vivo Product Portfolio
6.15.5 Astellas Recent Developments/Updates
6.16 Covis Pharma
6.16.1 Covis Pharma Company Information
6.16.2 Covis Pharma Description and Business Overview
6.16.3 Covis Pharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Covis Pharma Drug Delivery System in Vivo Product Portfolio
6.16.5 Covis Pharma Recent Developments/Updates
6.17 AbbVie
6.17.1 AbbVie Company Information
6.17.2 AbbVie Description and Business Overview
6.17.3 AbbVie Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.17.4 AbbVie Drug Delivery System in Vivo Product Portfolio
6.17.5 AbbVie Recent Developments/Updates
6.18 Dr Reddy
6.18.1 Dr Reddy Company Information
6.18.2 Dr Reddy Description and Business Overview
6.18.3 Dr Reddy Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Dr Reddy Drug Delivery System in Vivo Product Portfolio
6.18.5 Dr Reddy Recent Developments/Updates
6.19 AstraZeneca
6.19.1 AstraZeneca Company Information
6.19.2 AstraZeneca Description and Business Overview
6.19.3 AstraZeneca Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AstraZeneca Drug Delivery System in Vivo Product Portfolio
6.19.5 AstraZeneca Recent Developments/Updates
6.20 Aspen Pharmacare
6.20.1 Aspen Pharmacare Company Information
6.20.2 Aspen Pharmacare Description and Business Overview
6.20.3 Aspen Pharmacare Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Aspen Pharmacare Drug Delivery System in Vivo Product Portfolio
6.20.5 Aspen Pharmacare Recent Developments/Updates
6.21 Acrotech Biopharma
6.21.1 Acrotech Biopharma Company Information
6.21.2 Acrotech Biopharma Description and Business Overview
6.21.3 Acrotech Biopharma Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Acrotech Biopharma Drug Delivery System in Vivo Product Portfolio
6.21.5 Acrotech Biopharma Recent Developments/Updates
6.22 TWi Pharmaceuticals(Bora Pharma)
6.22.1 TWi Pharmaceuticals(Bora Pharma) Company Information
6.22.2 TWi Pharmaceuticals(Bora Pharma) Description and Business Overview
6.22.3 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales, Revenue and Gross Margin (2020-2025)
6.22.4 TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product Portfolio
6.22.5 TWi Pharmaceuticals(Bora Pharma) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Delivery System in Vivo Industry Chain Analysis
7.2 Drug Delivery System in Vivo Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Delivery System in Vivo Production Mode & Process Analysis
7.4 Drug Delivery System in Vivo Sales and Marketing
7.4.1 Drug Delivery System in Vivo Sales Channels
7.4.2 Drug Delivery System in Vivo Distributors
7.5 Drug Delivery System in Vivo Customer Analysis
8 Drug Delivery System in Vivo Market Dynamics
8.1 Drug Delivery System in Vivo Industry Trends
8.2 Drug Delivery System in Vivo Market Drivers
8.3 Drug Delivery System in Vivo Market Challenges
8.4 Drug Delivery System in Vivo Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Drug Delivery System in Vivo Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drug Delivery System in Vivo Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drug Delivery System in Vivo Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drug Delivery System in Vivo Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drug Delivery System in Vivo Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drug Delivery System in Vivo Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drug Delivery System in Vivo Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drug Delivery System in Vivo Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drug Delivery System in Vivo, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
Table 12. Global Key Manufacturers of Drug Delivery System in Vivo, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Delivery System in Vivo by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery System in Vivo as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Delivery System in Vivo Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drug Delivery System in Vivo Sales by Region (2020-2025) & (K Units)
Table 18. Global Drug Delivery System in Vivo Sales Market Share by Region (2020-2025)
Table 19. Global Drug Delivery System in Vivo Sales by Region (2026-2031) & (K Units)
Table 20. Global Drug Delivery System in Vivo Sales Market Share by Region (2026-2031)
Table 21. Global Drug Delivery System in Vivo Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drug Delivery System in Vivo Revenue Market Share by Region (2020-2025)
Table 23. Global Drug Delivery System in Vivo Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drug Delivery System in Vivo Revenue Market Share by Region (2026-2031)
Table 25. North America Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 27. North America Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 28. North America Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drug Delivery System in Vivo Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drug Delivery System in Vivo Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drug Delivery System in Vivo Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drug Delivery System in Vivo Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drug Delivery System in Vivo Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drug Delivery System in Vivo Sales (K Units) by Type (2020-2025)
Table 51. Global Drug Delivery System in Vivo Sales (K Units) by Type (2026-2031)
Table 52. Global Drug Delivery System in Vivo Sales Market Share by Type (2020-2025)
Table 53. Global Drug Delivery System in Vivo Sales Market Share by Type (2026-2031)
Table 54. Global Drug Delivery System in Vivo Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drug Delivery System in Vivo Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drug Delivery System in Vivo Revenue Market Share by Type (2020-2025)
Table 57. Global Drug Delivery System in Vivo Revenue Market Share by Type (2026-2031)
Table 58. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drug Delivery System in Vivo Sales (K Units) by Application (2020-2025)
Table 61. Global Drug Delivery System in Vivo Sales (K Units) by Application (2026-2031)
Table 62. Global Drug Delivery System in Vivo Sales Market Share by Application (2020-2025)
Table 63. Global Drug Delivery System in Vivo Sales Market Share by Application (2026-2031)
Table 64. Global Drug Delivery System in Vivo Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drug Delivery System in Vivo Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drug Delivery System in Vivo Revenue Market Share by Application (2020-2025)
Table 67. Global Drug Delivery System in Vivo Revenue Market Share by Application (2026-2031)
Table 68. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2026-2031)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Amgen Drug Delivery System in Vivo Product
Table 74. Amgen Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Drug Delivery System in Vivo Product
Table 79. Teva Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche Drug Delivery System in Vivo Product
Table 84. Roche Recent Developments/Updates
Table 85. UCB (Union Chimique Belge) Company Information
Table 86. UCB (Union Chimique Belge) Description and Business Overview
Table 87. UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. UCB (Union Chimique Belge) Drug Delivery System in Vivo Product
Table 89. UCB (Union Chimique Belge) Recent Developments/Updates
Table 90. Celgene Company Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Celgene Drug Delivery System in Vivo Product
Table 94. Celgene Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck Drug Delivery System in Vivo Product
Table 99. Merck Recent Developments/Updates
Table 100. Gilead Sciences Company Information
Table 101. Gilead Sciences Description and Business Overview
Table 102. Gilead Sciences Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Drug Delivery System in Vivo Product
Table 104. Gilead Sciences Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Drug Delivery System in Vivo Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Drug Delivery System in Vivo Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Takeda Company Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Takeda Drug Delivery System in Vivo Product
Table 119. Takeda Recent Developments/Updates
Table 120. Bausch&Lomb Company Information
Table 121. Bausch&Lomb Description and Business Overview
Table 122. Bausch&Lomb Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Bausch&Lomb Drug Delivery System in Vivo Product
Table 124. Bausch&Lomb Recent Developments/Updates
Table 125. Samyang Biopharmaceuticals Company Information
Table 126. Samyang Biopharmaceuticals Description and Business Overview
Table 127. Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Samyang Biopharmaceuticals Drug Delivery System in Vivo Product
Table 129. Samyang Biopharmaceuticals Recent Developments/Updates
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Johnson & Johnson Drug Delivery System in Vivo Product
Table 134. Johnson & Johnson Recent Developments/Updates
Table 135. TOLMAR Company Information
Table 136. TOLMAR Description and Business Overview
Table 137. TOLMAR Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. TOLMAR Drug Delivery System in Vivo Product
Table 139. TOLMAR Recent Developments/Updates
Table 140. Astellas Company Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Astellas Drug Delivery System in Vivo Product
Table 144. Astellas Recent Developments/Updates
Table 145. Covis Pharma Company Information
Table 146. Covis Pharma Description and Business Overview
Table 147. Covis Pharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Covis Pharma Drug Delivery System in Vivo Product
Table 149. Covis Pharma Recent Developments/Updates
Table 150. AbbVie Company Information
Table 151. AbbVie Description and Business Overview
Table 152. AbbVie Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. AbbVie Drug Delivery System in Vivo Product
Table 154. AbbVie Recent Developments/Updates
Table 155. Dr Reddy Company Information
Table 156. Dr Reddy Description and Business Overview
Table 157. Dr Reddy Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Dr Reddy Drug Delivery System in Vivo Product
Table 159. Dr Reddy Recent Developments/Updates
Table 160. AstraZeneca Company Information
Table 161. AstraZeneca Description and Business Overview
Table 162. AstraZeneca Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. AstraZeneca Drug Delivery System in Vivo Product
Table 164. AstraZeneca Recent Developments/Updates
Table 165. Aspen Pharmacare Company Information
Table 166. Aspen Pharmacare Description and Business Overview
Table 167. Aspen Pharmacare Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Aspen Pharmacare Drug Delivery System in Vivo Product
Table 169. Aspen Pharmacare Recent Developments/Updates
Table 170. Acrotech Biopharma Company Information
Table 171. Acrotech Biopharma Description and Business Overview
Table 172. Acrotech Biopharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Acrotech Biopharma Drug Delivery System in Vivo Product
Table 174. Acrotech Biopharma Recent Developments/Updates
Table 175. TWi Pharmaceuticals(Bora Pharma) Company Information
Table 176. TWi Pharmaceuticals(Bora Pharma) Description and Business Overview
Table 177. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product
Table 179. TWi Pharmaceuticals(Bora Pharma) Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Drug Delivery System in Vivo Distributors List
Table 183. Drug Delivery System in Vivo Customers List
Table 184. Drug Delivery System in Vivo Market Trends
Table 185. Drug Delivery System in Vivo Market Drivers
Table 186. Drug Delivery System in Vivo Market Challenges
Table 187. Drug Delivery System in Vivo Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Delivery System in Vivo
Figure 2. Global Drug Delivery System in Vivo Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Delivery System in Vivo Market Share by Type: 2024 & 2031
Figure 4. Carrier Formulation Delivery Product Picture
Figure 5. Targeted Delivery Product Picture
Figure 6. Global Drug Delivery System in Vivo Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Delivery System in Vivo Market Share by Application: 2024 & 2031
Figure 8. Small Molecule Drug
Figure 9. Proteins and Peptides
Figure 10. Antibody
Figure 11. Nucleic Acids
Figure 12. Others
Figure 13. Global Drug Delivery System in Vivo Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drug Delivery System in Vivo Market Size (2020-2031) & (US$ Million)
Figure 15. Global Drug Delivery System in Vivo Sales (2020-2031) & (K Units)
Figure 16. Global Drug Delivery System in Vivo Average Price (US$/Unit) & (2020-2031)
Figure 17. Drug Delivery System in Vivo Report Years Considered
Figure 18. Drug Delivery System in Vivo Sales Share by Manufacturers in 2024
Figure 19. Global Drug Delivery System in Vivo Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Drug Delivery System in Vivo Players: Market Share by Revenue in Drug Delivery System in Vivo in 2024
Figure 21. Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Drug Delivery System in Vivo Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 24. North America Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 25. United States Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 28. Europe Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 29. Germany Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Drug Delivery System in Vivo Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Drug Delivery System in Vivo Revenue Market Share by Region (2020-2031)
Figure 36. China Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 44. Latin America Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Drug Delivery System in Vivo by Type (2020-2031)
Figure 55. Global Revenue Market Share of Drug Delivery System in Vivo by Type (2020-2031)
Figure 56. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Drug Delivery System in Vivo by Application (2020-2031)
Figure 58. Global Revenue Market Share of Drug Delivery System in Vivo by Application (2020-2031)
Figure 59. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2020-2031)
Figure 60. Drug Delivery System in Vivo Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Drug Delivery System in Vivo Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drug Delivery System in Vivo Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drug Delivery System in Vivo Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drug Delivery System in Vivo Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drug Delivery System in Vivo Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drug Delivery System in Vivo Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drug Delivery System in Vivo Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drug Delivery System in Vivo Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drug Delivery System in Vivo, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Delivery System in Vivo, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Delivery System in Vivo, Product Type & Application
Table 12. Global Key Manufacturers of Drug Delivery System in Vivo, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Delivery System in Vivo by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery System in Vivo as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Delivery System in Vivo Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drug Delivery System in Vivo Sales by Region (2020-2025) & (K Units)
Table 18. Global Drug Delivery System in Vivo Sales Market Share by Region (2020-2025)
Table 19. Global Drug Delivery System in Vivo Sales by Region (2026-2031) & (K Units)
Table 20. Global Drug Delivery System in Vivo Sales Market Share by Region (2026-2031)
Table 21. Global Drug Delivery System in Vivo Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drug Delivery System in Vivo Revenue Market Share by Region (2020-2025)
Table 23. Global Drug Delivery System in Vivo Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drug Delivery System in Vivo Revenue Market Share by Region (2026-2031)
Table 25. North America Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 27. North America Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 28. North America Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drug Delivery System in Vivo Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drug Delivery System in Vivo Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drug Delivery System in Vivo Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drug Delivery System in Vivo Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drug Delivery System in Vivo Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drug Delivery System in Vivo Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drug Delivery System in Vivo Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drug Delivery System in Vivo Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drug Delivery System in Vivo Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drug Delivery System in Vivo Sales (K Units) by Type (2020-2025)
Table 51. Global Drug Delivery System in Vivo Sales (K Units) by Type (2026-2031)
Table 52. Global Drug Delivery System in Vivo Sales Market Share by Type (2020-2025)
Table 53. Global Drug Delivery System in Vivo Sales Market Share by Type (2026-2031)
Table 54. Global Drug Delivery System in Vivo Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drug Delivery System in Vivo Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drug Delivery System in Vivo Revenue Market Share by Type (2020-2025)
Table 57. Global Drug Delivery System in Vivo Revenue Market Share by Type (2026-2031)
Table 58. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drug Delivery System in Vivo Sales (K Units) by Application (2020-2025)
Table 61. Global Drug Delivery System in Vivo Sales (K Units) by Application (2026-2031)
Table 62. Global Drug Delivery System in Vivo Sales Market Share by Application (2020-2025)
Table 63. Global Drug Delivery System in Vivo Sales Market Share by Application (2026-2031)
Table 64. Global Drug Delivery System in Vivo Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drug Delivery System in Vivo Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drug Delivery System in Vivo Revenue Market Share by Application (2020-2025)
Table 67. Global Drug Delivery System in Vivo Revenue Market Share by Application (2026-2031)
Table 68. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2026-2031)
Table 70. Amgen Company Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Amgen Drug Delivery System in Vivo Product
Table 74. Amgen Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Drug Delivery System in Vivo Product
Table 79. Teva Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Roche Drug Delivery System in Vivo Product
Table 84. Roche Recent Developments/Updates
Table 85. UCB (Union Chimique Belge) Company Information
Table 86. UCB (Union Chimique Belge) Description and Business Overview
Table 87. UCB (Union Chimique Belge) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. UCB (Union Chimique Belge) Drug Delivery System in Vivo Product
Table 89. UCB (Union Chimique Belge) Recent Developments/Updates
Table 90. Celgene Company Information
Table 91. Celgene Description and Business Overview
Table 92. Celgene Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Celgene Drug Delivery System in Vivo Product
Table 94. Celgene Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Merck Drug Delivery System in Vivo Product
Table 99. Merck Recent Developments/Updates
Table 100. Gilead Sciences Company Information
Table 101. Gilead Sciences Description and Business Overview
Table 102. Gilead Sciences Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Gilead Sciences Drug Delivery System in Vivo Product
Table 104. Gilead Sciences Recent Developments/Updates
Table 105. Sanofi Company Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Sanofi Drug Delivery System in Vivo Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Drug Delivery System in Vivo Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Takeda Company Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Takeda Drug Delivery System in Vivo Product
Table 119. Takeda Recent Developments/Updates
Table 120. Bausch&Lomb Company Information
Table 121. Bausch&Lomb Description and Business Overview
Table 122. Bausch&Lomb Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Bausch&Lomb Drug Delivery System in Vivo Product
Table 124. Bausch&Lomb Recent Developments/Updates
Table 125. Samyang Biopharmaceuticals Company Information
Table 126. Samyang Biopharmaceuticals Description and Business Overview
Table 127. Samyang Biopharmaceuticals Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Samyang Biopharmaceuticals Drug Delivery System in Vivo Product
Table 129. Samyang Biopharmaceuticals Recent Developments/Updates
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Johnson & Johnson Drug Delivery System in Vivo Product
Table 134. Johnson & Johnson Recent Developments/Updates
Table 135. TOLMAR Company Information
Table 136. TOLMAR Description and Business Overview
Table 137. TOLMAR Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. TOLMAR Drug Delivery System in Vivo Product
Table 139. TOLMAR Recent Developments/Updates
Table 140. Astellas Company Information
Table 141. Astellas Description and Business Overview
Table 142. Astellas Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Astellas Drug Delivery System in Vivo Product
Table 144. Astellas Recent Developments/Updates
Table 145. Covis Pharma Company Information
Table 146. Covis Pharma Description and Business Overview
Table 147. Covis Pharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Covis Pharma Drug Delivery System in Vivo Product
Table 149. Covis Pharma Recent Developments/Updates
Table 150. AbbVie Company Information
Table 151. AbbVie Description and Business Overview
Table 152. AbbVie Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. AbbVie Drug Delivery System in Vivo Product
Table 154. AbbVie Recent Developments/Updates
Table 155. Dr Reddy Company Information
Table 156. Dr Reddy Description and Business Overview
Table 157. Dr Reddy Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Dr Reddy Drug Delivery System in Vivo Product
Table 159. Dr Reddy Recent Developments/Updates
Table 160. AstraZeneca Company Information
Table 161. AstraZeneca Description and Business Overview
Table 162. AstraZeneca Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. AstraZeneca Drug Delivery System in Vivo Product
Table 164. AstraZeneca Recent Developments/Updates
Table 165. Aspen Pharmacare Company Information
Table 166. Aspen Pharmacare Description and Business Overview
Table 167. Aspen Pharmacare Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Aspen Pharmacare Drug Delivery System in Vivo Product
Table 169. Aspen Pharmacare Recent Developments/Updates
Table 170. Acrotech Biopharma Company Information
Table 171. Acrotech Biopharma Description and Business Overview
Table 172. Acrotech Biopharma Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Acrotech Biopharma Drug Delivery System in Vivo Product
Table 174. Acrotech Biopharma Recent Developments/Updates
Table 175. TWi Pharmaceuticals(Bora Pharma) Company Information
Table 176. TWi Pharmaceuticals(Bora Pharma) Description and Business Overview
Table 177. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. TWi Pharmaceuticals(Bora Pharma) Drug Delivery System in Vivo Product
Table 179. TWi Pharmaceuticals(Bora Pharma) Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Drug Delivery System in Vivo Distributors List
Table 183. Drug Delivery System in Vivo Customers List
Table 184. Drug Delivery System in Vivo Market Trends
Table 185. Drug Delivery System in Vivo Market Drivers
Table 186. Drug Delivery System in Vivo Market Challenges
Table 187. Drug Delivery System in Vivo Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Delivery System in Vivo
Figure 2. Global Drug Delivery System in Vivo Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Delivery System in Vivo Market Share by Type: 2024 & 2031
Figure 4. Carrier Formulation Delivery Product Picture
Figure 5. Targeted Delivery Product Picture
Figure 6. Global Drug Delivery System in Vivo Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Drug Delivery System in Vivo Market Share by Application: 2024 & 2031
Figure 8. Small Molecule Drug
Figure 9. Proteins and Peptides
Figure 10. Antibody
Figure 11. Nucleic Acids
Figure 12. Others
Figure 13. Global Drug Delivery System in Vivo Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Drug Delivery System in Vivo Market Size (2020-2031) & (US$ Million)
Figure 15. Global Drug Delivery System in Vivo Sales (2020-2031) & (K Units)
Figure 16. Global Drug Delivery System in Vivo Average Price (US$/Unit) & (2020-2031)
Figure 17. Drug Delivery System in Vivo Report Years Considered
Figure 18. Drug Delivery System in Vivo Sales Share by Manufacturers in 2024
Figure 19. Global Drug Delivery System in Vivo Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Drug Delivery System in Vivo Players: Market Share by Revenue in Drug Delivery System in Vivo in 2024
Figure 21. Drug Delivery System in Vivo Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Drug Delivery System in Vivo Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 24. North America Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 25. United States Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 28. Europe Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 29. Germany Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Drug Delivery System in Vivo Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Drug Delivery System in Vivo Revenue Market Share by Region (2020-2031)
Figure 36. China Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 44. Latin America Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Drug Delivery System in Vivo Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Drug Delivery System in Vivo Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Drug Delivery System in Vivo Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Drug Delivery System in Vivo by Type (2020-2031)
Figure 55. Global Revenue Market Share of Drug Delivery System in Vivo by Type (2020-2031)
Figure 56. Global Drug Delivery System in Vivo Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Drug Delivery System in Vivo by Application (2020-2031)
Figure 58. Global Revenue Market Share of Drug Delivery System in Vivo by Application (2020-2031)
Figure 59. Global Drug Delivery System in Vivo Price (US$/Unit) by Application (2020-2031)
Figure 60. Drug Delivery System in Vivo Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232